医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

D. One Vision Management Leads $16 Million Series A Investment In PrinterPrezz

2020年12月10日 PM02:43
このエントリーをはてなブックマークに追加


 

NEW YORK

D. One Vision Management with its DOV Singularity Fund, an alternative investment vehicle for investors seeking growth and diversification in tech-empowered future, today announced the addition of PrinterPrezz, the first MedifacturingTM company in the world to its investment portfolio. Through its DOV Singularity Fund, D. One Vision Management served as the lead investor in PrinterPrezz’s recently completed $16 million Series A funding. Other lead investors in the round include Boutique Venture Partners, Berkeley Catalyst Fund while Solvay Ventures served as strategic investor.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201209006094/en/

David You, Founder & CEO, D. One Vision Management (Photo: Business Wire)

David You, Founder & CEO, D. One Vision Management (Photo: Business Wire)

PrinterPrezz, Inc. headquartered in California, U.S. with a subsidiary in Singapore, combines robust additive manufacturing technology platforms, nanotechnologies and surgical expertise to develop next generation medical devices from concept and design through FDA approval and volume production.

David You, Founder and CEO of D. One Vision Management, commented, “As the first external investor who identified PrinterPrezz and the lead investor of this round, we believe the Medifacturing™ infrastructure with the foundry ecosystem that PrinterPrezz is building will bring about a new era in the health care industry, which fits our investment philosophy perfectly, applying technology to the betterment of the global human population towards the singularity era. Empowered by its proprietary end-to-end ecosystem for medical device companies, PrinterPrezz’s total available market will expand significantly, if not exponentially in the near future.”

Claire Zhang, Founding Partner of D. One Vision Management, added, “The recent FDA approval of PrinterPrezz’s six medical devices was a strong validation of the company’s vision and business model. We are very excited to collaborate with this enthusiastic and multi-disciplinary team to further grow the business.”

Shri Shetty, CEO of PrinterPrezz, commented, “We believe that the future of medical device development is in the joining of novel materials with proprietary technology. PrinterPrezz continues to offer opportunities for innovative medical device companies to leverage our infrastructure and know-how to speed their time-to-market. We are delighted to have DOV’s support and shared vision of technology’s potential to drive meaningful improvements for people as they live longer, more active lives.”

About D. One Vision Management

D. One Vision Management (DOV) is a New York-based firm investing in hardcore technologies and disruptive solutions. With its flagship fund, DOV Singularity Fund (DOVSF), DOV aims to create an investment ecosystem. To shape the future of singularity, we dedicate capital to support human-centered technological development that enable a better future of the world and make the maximum positive impact for human society. We strive to create value by investing in great businesses where DOV’s capital, strategic insight, global relationships and operational support can drive transformation. By leveraging the contrarian culture and willingness to embrace complexity, we will identify different paths to value across economic cycles. www.dreamonevision.com

About PrinterPrezz

PrinterPrezz’s mission is to bring more ideas for innovative medical devices to market faster, connecting medicine and manufacturing to become the first Medifacturing™ company in the world. By developing advanced medical devices using processes that combine expertise in 3D printing, orthopaedics, semiconductor and nanotechnologies, PrinterPrezz’s ultimate goal is to provide medical solutions that enable people to enjoy active lives longer. PrinterPrezz’s ecosystem aims to solve challenges for various parts of the medical innovation value chain by providing prototyping, development, and manufacturing services to create life-enhancing medical devices. Committed to ongoing compliance with ISO13485:2016 and all relevant regulatory requirements including 21CFR211 and 21CFR820, PrinterPrezz provides customers with access to a variety of 3D printing machines, 3D manipulation software, and 3D scanners as well as advanced manufacturing processes, and surgeon education programs. Medical solutions created by PrinterPrezz are designed to enable more people to live happier and more gratifying lives. For additional information about the company, please visit www.printerprezz.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20201209006094/en/

CONTACT

Claire Zhang

D. One Vision Management (DOV)

Email us here: hello@dreamonevision.com

Website: www.dreamonevision.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • BioNet and Sartorius’ Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines
  • ZAP Surgical Appoints Industry Veterans to Lead Chinese Market Expansion
  • ZAP Surgical 任命 业 内 资 深人士 领导 中国市 场 的拓展工作
  • 武田创造强劲的2021财年上半年业绩;受14个全球品牌的推动,增长态势有望进一步持续到财年年底
  • Seoul Semiconductor’s SunLike Natural Spectrum LEDs Selected by European Premium Lighting Brand LEDVANCE